Suchergebnisse - "Lorini, Luigi"

PubPharm (46)

31

Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group

enthalten in: Frontiers in oncology | 2022

von Klinghammer, K. | Lorini, L. | Nevens, D. | +3

32

Treatment of Cutaneous Squamous Cell Carcinoma with Immune Checkpoint Inhibitors in Special Populations

enthalten in: Dermatology practical & conceptual | 2021

von Bossi, P. | Lorini, L.

33

Not all hematopoietic growth factors are created equal : should we gain information for their use with immunotherapy?

enthalten in: Journal for immunotherapy of cancer | 2021

von Bossi, P. | Gurizzan, C. | Lorini, L. | +3

ErratumIn: J Immunother Cancer. 2021 Nov;9(11):. - PMID 34782435

34

Overview of Oral Potentially Malignant Disorders : From Risk Factors to Specific Therapies

enthalten in: Cancers | 2021

von Lorini, L. | Bescós Atín, C. | Thavaraj, S. | +9

35

Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets

enthalten in: Cancers | 2021

von Romani, C. | Bignotti, E. | Mattavelli, D. | +23

36

Immunotherapy for the prevention of high-risk oral disorders malignant transformation : the IMPEDE trial

enthalten in: BMC cancer | 2021

von Gurizzan, C. | Lorini, L. | Paderno, A. | +15

37

Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial

enthalten in: BMC cancer | 2021

von Gurizzan, C. | Lorini, L. | Paderno, A. | +15

38

Brain metastasis in head and neck squamous cell carcinoma after immune check point inhibitors treatment

enthalten in: Oral oncology | 2021

von Lorini, L. | Merlano, M. | Licitra, L. | +2

39

In vitro and in vivo evaluation of cytotoxic effect of targeted agents alone or in combination with chemotherapy for the treatment of adenoid cystic carcinoma

enthalten in: ResearchSquare.com | 2021

von Savarese, T. | Abate, A. | Basnet, R. | +11

40

Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma

enthalten in: Oral oncology | 2021

von Lorini, L. | Ardighieri, L. | Bozzola, A. | +12